The in vivo interaction of leukemogenic and nonleukemogenic viruses was studied. This interaction may result in an inhibition of leukemia virus replication, as demonstrated with Sendai virus (11, 12) and lymphocytic choriomeningitis virus (13) , or the leukemia virus may enhance the nonleukemogenic virus as demonstrated with mouse hepatitis virus and murine leukemia virus (3) , and murine sarcoma virus by murine leukemia virus (2) . In contrast, leukemia virus replication may be enhanced without apparent nonleukemogenic virus replication as reported with Guaroa virus (GV; 10), an arbovirus of the Bunyamwera group; with Newcastle disease virus; and lactic dehydrogenase-elevating virus (9) .
The mechanism by which a nonleukemogenic virus inhibits replication of leukemia viruses is thought to be mediated through interferon stimulation (4, 5) ; although the mechanism by which a nonleukemogenic virus enhances the replication of leukemia viruses is unproven, the enhancement may be due to an increase in the number of leukemia virus target cells in the spleen (9) .
This report concerns the quantitative analyses of the enhancement of Friend leukemia virus (FLV), leukemogenesis by GV, and additional studies of various oncogenic and nononcogenic viruses as to their ability to enhance FLV leukemogenesis.
MATERIALS AND spleen preparation, a fivefold increase of recoverable virus was noted (P < 0.01). By the 14th day spleen foci determinations were no longer sensitive, as foci were confluent and uncountable due to the infection. However, differences were still observed in mice receiving the lower dose of FLV (20 SED50) in two of the three parameters examined (Table 2 ). An increase in mean spleen weight of 127 mg (P < 0.01) and in recoverable virus from spleen extracts of nearly sevenfold (P < 0.01) was seen in coinfected mice when compared to FLV alone.
Comparison of viruses to GV for the enhancement of FLV leukemogenesis. By using the low dose (20 SED5o) for FLV infection, various viruses were tested for their capacity to enhance FLV activity. From the previous data, the most significant information could be obtained from spleen foci counts that were enumerated at 7 days, from the mean spleen weight data that was collected at 14 days, and from the bioassay of plasma (7 days) and spleen (14 days). With each virus, a comparison is made with GV for determining the enhancement of FLV leukemogenesis (Table 3) .
Although a significant increase in spleen foci was observed with VSV and vaccinia, neither virus approached GV in increased infectivity as determined by spleen focus analysis. With spleen weight analysis, VSV produced a significant increase in spleen weight greater than GV. In the bioassay of plasma and spleen from co-infected mice, the amount of recoverable FLV was not significantly (P > 0.10) greater when compared with GV. Both VSV and vaccinia were capable of increasing recoverable virus from plasma; when compared with the FLV control, the differences expressed between GV and these viruses were not significant, and neither of the viruses exhibited increased ability to enhance infection when harvested from spleens of co-infected mice. Although VSV gave the best indication of the other viruses tested as being able to enhance FLV leukemogenesis, it did not enhance leukemogenesis in the test parameters to the same degree as observed for GV. Of the other viruses tested, vaccinia and RSV each showed an ability to increase infectivity of FLV, but none approached GV in increasing leukemogenesis. Except for increasing the amount of FLV recovered from the plasma, herpesvirus decreased leukemogenic activity. Influenza caused an increase in spleen weight, but none of the other test systems were affected by influenza.
None of the viruses tested had the ability to induce spleen foci or cause an increased spleen weight when given to the mice without FLV.
DISCUSSION
The interaction of viruses plays an important role in infection or disease processes in an animal. Perhaps interaction plays a more important role than single virus in the study of natural infections. There are many reactions that could trigger a latent or subliminal infection and cause a disease to become manifest. This study was concerned with the ability of an unrelated virus causing an enhancement of leukemia. FLV was chosen for its short latent period in the observance of infection. GV was previously shown (9) to enhance the leukemia response of FLV and Rausher leukemia virus (RLV). The ability of virus to enhance the leukemic response was found to be related to the amount of input leukemia virus. If too much leukemia virus was administered, an overwhelming response was observed, which tended to obliterate the interaction of another virus. If, however, a quantity of leukemia virus was administered that, by itself, did not induce an early and overwhelming disease but rather gave a diminished but interpretable response, the effect of coinfection could be measured. When a concentration of FLV, sufficient to cause only a minimal response was used, prior co-infection with GV increased the number of spleen foci nearly ninefold, increased the mean weight of spleens harvested at 7 and 14 days, and greatly increased the amount of recoverable virus from the plasma at 7 days and from the spleen at 14 days. An early viremia would account for the amount of virus recovered from the plasma, and the later increases in virus concentrations, such as in the spleen, could be attributed to infectious viruses being absorbed by internal organs. GV by itself is refractory in the adult mouse (5), and there was no evidence of GV being present in plasma or spleen preparations. The action of GV is thought to be due to increased numbers of spleen cells suceptible to FLV infection.
Since GV is an arbovirus with the size and ribonucleic acid content similar to leukemia viruses, different other viruses were tested to see whether they also enhanced FLV infection. Although VSV somewhat increased the response of FLV infection, the degree of response was not as great as noted with GV. The other viruses, vaccinia, RSV, influenza, and herpesvirus, had little effect on enhancing leukemia. None of the viruses tested had the ability to increase the splenic response by itself.
